The Power of Proteomics in Medicine

mass_spectrometry_proteomics

  Although genomic (DNA) and transcriptomic (messenger RNA) data are easier to collect and analyze, these are only two of the relevant types of “omic” data that are important for understanding disease and the response to treatments. Proteomic, metabolomic, and lipidomic data are also contain information that can be used diagnostically, prognostically, in developing treatment … Read more

The Power of Proteomics in Building the Human Protein Interaction Network

CDK4_Interaction_Network

Defining >56,000 Human Protein Interactions through Mass Spectrometry Huttlin and colleagues applied mass spectrometric analysis to affinity purified protein complexes to help build a partial reference map of the human protein interaction space (1). The cDNA encoding the target proteins also engineered to have affinity tags (hemagglutinin and FLAG) were introduced into an easily infected … Read more

Proteomic Analysis Leads to Insights into Heart Failure

dilated_cardiomyopathy

Although mass spectrometry-based proteomic analysis is particularly useful for performing global proteomic analysis, this technique can also be used in a more targeted manner. For example, mass spectrometry-based proteomic analysis can be combined with immunoprecipitation to reveal the proteins that interact with the immunoprecipitated protein. Quick and colleagues (1) used coimmunoprecipitation followed by mass spectrometric … Read more

Can Denosumab Prevent Breast Cancer?

Structure_model_denosumab_OPG_RANKL

From Osteoporosis to Breast Cancer Denosumab, a biologic agent, and bisphosphonates, which are small molecule drugs, reduce fractures that are complications of osteoporosis, including those caused by breast cancer hormone therapies that block estrogen signaling, menopause, or surgically-induced menopause (oophorectomy with or without hysterectomy). Both denosumab and bisphosphonates also reduce the risk of bone metastasis … Read more